**Cystic Fibrosis** Notes :
|
|
- Clarence Richard
- 5 years ago
- Views:
Transcription
1 **Cystic Fibrosis** Notes : - the slides are included in the lecture. - everything in Italic is just important things from the old lecture. - It s easy lecture, even it seems long.. GOOD LUCK Cystic fibrosis is the most common lethal genetic disease and it has autosomal recessive inheritance. Which means that we need 2 mutations to give us the full picture of the disease. One mutation predispose the person to have kids that are carriers but not affected with the disease. Mutations occur in cystic fibrosis transmembrane conductance regulator (CFTR) protein which functions as a chloride channel. Unfortunately, we don t have registry for cystic fibrosis patients in Jordan and the middle east so we don t have an exact life span for patients. But Median Predicted age of survival is 38 according to the US annual report in About 1500 mutations were identified in CFTR gene. but not all of them cause the disease, they may have different manifestations. The most common mutation that cause CF is delta f508, it accounts about 2/3 of mutations in Northern European and North American Population. * f508: - : deletion. - F : phenylalanine : the position of the deleted PA in the sequence of amino acids of CFTR. This map show the incidence of cystic fibrosis all over the world, is common in the white population (Caucasian) and least common in the African American. Also, the incidence is not known in our areas but it s less common. We are considered according to them Others, neither white nor black. 1
2 CFTR Protein (Chloride Channel ) The doctor showed a video about types of mutations in CFTR gene, but it s not present in the slide that she gave us. (Search it on youtube if you like ). You expect from having different mutations, that severity of the disease is different. The delta F508 mutation belongs to the trafficking mutation where the protein is synthesized but is not targeted to the surface of the cell membrane. The chloride channels are present in the epithelial cells mainly in the respiratory epithelium, GI tract, sweat glands and reproductive tract. ** Function Of CFTR protein. Look at this diagram, you can see that normal CFTR protein in the respiratory epithelium functions as Cl - channels ( Cl - excretion) and cause inhibition of Na absorption through the epithelial Na channels. Water will follow the electrolyte direction to the outside to keep the airway surface layer ASL well hydrated. 2
3 When mutation occurs, dysfunctional CFTR lead to 1 loss of Cl excretion, 2 Na and water absorption resulting in dehydration and retraction of ASL layer. Cilia need a good media to beat, so decrease in the water volume result in reduction in lubricating layer between epithelium and mucus layer (which become thick ) with compression of the cilia by mucus causing inhibition of normal ciliary and cough clearance of mucus. Diagnostic Criteria for CF We diagnose it according to CF Foundation Consensus Panel. We need either 1 one of the clinical manifestation of CF (Respiratory,GI or salt loss syndromes ) or 2 positive family history of CF or 3 +ve newborn screening PLUS we need a biochemical test to confirm the Dx which are 1 abnormal seat chloride test or 2 detection of genetic mutation or 3 abnormal Nasal Potential Difference (NPD is used for research purposes which measure the ve charge of nasal mucosa ). 3
4 Sweat chloride test The sweat test is the Gold Standard for testing for CF and it s painless, inexpensive and gives definite answers. The function of chloride channels in sweat glands is the absorption of chloride ions (opposite to that of respiratory epithelium) because we need to reserve the fluid and prevent dehydration. Once mutated, the chloride will be excreted and that will give the salty taste of skin in patients with CF. ** How the Sweat chloride test is done?? As you see in the figure, they hold the arm of the baby then, they apply pilocarpine iontophoresis that will stimulate sweating by cholinergic stimulation. Above the medication, they apply an electrode that help in the penetration of medication into the skin. Then they put a gauze of filter paper over the forearm to absorb the sweat and finally they take the gauze to test the sweat for chloride concentration. Sweat chloride concentration: - Normal: < 40 mmol/l 4
5 - Positive for CF : > 60mmol/L - Intermediate: mmol/l ( gray area that need further investigations). **We should repeat the test twice even it was +ve to diagnose CF. False Positive Sweat Test It occurs when the chloride test is positive but the patient is not having CF, it occurs in some endocrine abnormalities and others, which are : Adrenal insufficiency or stress Anorexia nervosa Ectodermal dysplasia Eczema Fucosidosis G6PD deficiency Glycogen storage disease type1 HIV infection Hypoparathyroidism Hypothyroidism Malnutrition Nephrogenic diabetes insipidus Psuedohypoaldosteronisim **Definitions of the some terms from wikipedia with modifications: (you can skip them if you want) Pseudohypoaldosteronism (PHA) is a condition that mimics hypoaldosteronism. However, the condition is due to a failure of response to aldosterone, and levels of aldosterone are actually elevated, due to a lack of feedback inhibition. 5
6 Ectodermal dysplasias are described as "heritable conditions in which there are abnormalities of two or more ectodermal structures such as the hair, teeth, nails, sweat glands, cranial-facial structure, digits and other parts of the body." Glycogen storage disease (GSDs) is the result of defects in the processing of glycogen synthesis or breakdown within muscles, liver, and other cell types. Type I is the most common one (called von Gierke's disease). Lysosomal storage diseases (LSDs) are a group of approximately 50 rare inherited metabolic disorders that result from defects in lysosomal function. Mucopolysaccharidosis and fucosidosis belong to this group. I remember a case in my training, a kid that is presented with poor growth, he didn t have any respiratory problems and have normal lung function, he was 10 yr-old and have a hx of sinusitis, we did the sweat test it was 90 but the picture didn t go with CF, after investigations he is found to have adrenal insufficiency ( he had pigmentation on his skin also) and treated with cortisone and the sweat test becomes 30. Occurs when the patients has : Dilution of sample Malnutrition False Negative Sweat Test Peripheral edema due to hypoalbuminemia. Hypoproteinemia Dehydration ** These FALSE positives and negatives are good for MCQs. Memorize them. 6
7 Newborn Screening It s of high importance but unfortunately it s not done in Jordan. It s done in the USA and Europe. It s important to screen for CF because we want to initiate the treatment as early as possible. If the newborn get the appropriate treatment, nutrition and respiratory care, this will prevent the deterioration in the lung function and improve the life span. **How do they Screen For CF in newborns?? First, they take a blood sample and measure the Immunoreactive trypsinogen level (one of the pancreatic enzymes ) which will be elevated in CF because of the pancreatic injury. If it s elevated, sweat test is needed to confirm the diagnosis. But the screening could miss pancreatic sufficient patients. (10-15% ) Pancreatic insufficiency occur in 85-90% of patients with CF. Clinical Manifestations of Cystic Fibrosis 7
8 As you see in the figure there are different manifestations of CF involving different systems of the body. We will start one by one. Pulmonary involvement In CF Majority of morbidity and mortality is related to lung diseases. Respiratory failure accounts about 80% of deaths of CF. As we said, the cilia are not beating in an appropriate environment because the mucous is very thick (because of Airway surface liquid (ASL) depletion) so the cilia are not able to clear the bacteria when needed. Also, this thick mucous is a very good media for bacteria to grow. As bacteria colonize the lungs, they produce cytokines ( inflammatory mediators like IL-8) that cause inflammation. During the inflammatory process ASL becomes infiltrated with neutrophils that respond to IL-8 secretion. Neutrophils will 1 release elastase and hazardous enzymes that are harmful to the lungs. Also, as 2 they die they release their DNA (which is sticky ) which contribute to the viscosity of the mucus ( so using aerosolized Dnase (Dornase alpha ) will thin the mucus and improve the lung function ). So, One this vicious circle starts, it will never end unless you interfere with your treatment and medications. And lastly, we will end with end stage lung disease. At this stage, lung transplantation is the only option to prevent ultimate death. but the 5 years survival in lung transplantation patient is also not high <50%. 8
9 This diagram shows the microorganisms that colonize the airways according to age. First, the lungs of children are normal at birth, then they start to become infected and inflamed. Typically infants become rapidly colonized by Hemophilus influenza or Staph.aureus bacteria. After a while, P.aeruginosa becomes the predominant organism in the airways, It colonizes the airways for several reasons: - Permissive microenvironments within the hypoxic niches of adherent plaques. - Increased binding to the epithelium. - Decreased bacterial clearance via innate immune mechanism. ** This is a list of pathogens that colonize the lungs : Staphylococcus aureus : we have also the Methicillin-Resistant S aureus (MRSA) which colonizes 15-20% of CF patients and is associated with poorer lung function Haemophilus influenza Pseudomonas aeruginosa : by time it will be transformed from the nonmucoid to the mucoid form by acquiring a biofilm. and that s why it s very very resistant to medication ( it s very difficult to eradicate the mucoid P.aeruginosa and is associated with increased inflammatory burden and sputum volume). Non mucoid strain can be eradicated with aggressive antibiotic regimen. Burkholderia cepacia : they are very nasty bugs, once you see it, you don t expect a good outcome. It almost impossible to eradicate it because they are resistant to antibiotics and very virulent, and cause rapid decline in lung function and increased mortality. 9
10 Stenotrophomonas maltophilia : is commonly found in CF patients sputum but the literature didn t show that it s associated with poor lung function or decrease survival. Nontuberculois mycobacteria : they can cause lung injury, bronchiectasis and they are very difficult to treat. You should use 2-3 medications for almost a year. Pulmonary manifestations - Cough is the most constant symptom because they relay on cough to clear their airways. - Wheezing and tachypnea. - Increased upper airway secretions, they would have persistent congestion and rhinorrhea. (all CF patients). - Sinusitis. - Nasal polyposis which will lead to nasal obstruction (Surgical resection is needed ). And they are recurrent even with surgical repair. ** always when you find it, screen for CF. - Recurrent Chest infections. - Hemoptysis ( because of the inflammatory process and invasion of blood vessels ), atelectasis, pneumothorax and cor pulmolnale (late signs and symptoms). - Persistent airway infections and inflammation cause bronchiectasis which is irreversible destruction and dilatation of the airways. **Cor pulmonale: "enlargement of the right ventricle of the heart as a response to increased resistance or high blood pressure in the lungs." Wikipedia ** Respiratory symptoms can be misdiagnosed as asthma or recurrent LRTI and the diagnosis can be delayed. 10
11 Nasal Polyp (surgical resection) Bronchiectasis Look at these rings, in the CT of a patient with bronchiectasis which represent the dilated airways. The white points in the both figures represent the vessels. So the airways beside the vessels appears as rings ( signet sign). Bronchiectasis in CF patients mainly involves the upper lobes and then it could extend to other lobes. 11
12 Gastrointestinal Manifestations Thick secretions are everywhere and GIT has it s secretion so every organ in the GI system will be involved. The manifestations are : Meconium ileus (15% of CF newborns) : Means Delay of the passage of meconium >48 hours after birth because of the thick intestinal secretions, the baby will have thick meconium and the delay occurs. Protracted jaundice : Means prolonged neonatal jaundice because the bile will be thick in the liver, so they develop obstructive Jaundice. Cholestasis then will develop and prolonged cholestasis will lead to biliary cirrhosis. 5% of patients will get liver cirrhosis after the age of 15years. Intestinal atresia Pancreatic insufficiency : the pancreas secrete the enzymes that are needed for digestion and absorption. In CF patient the exocrine function of the pancreas will be affected and cystic changes occur and by time, fibrosis will happen. Once exocrine part is fibrosed, the endocrine functions will be also affected and they will develop diabetes after 10 years of age. ( Mixed type 1 & 2 diabetes as they also have resistance to insulin with deficiency of insulin ). You should think of it after the age of 10 years, because it won t manifest as the typical picture of polydipsia, polyuria and polyphagia but will present with poor weight gain and delayed puberty) % of CF develop pancreatic insufficiency, which will be present at birth or evolve over the first year of life Pancreatitis CF-related DM Rectal prolapsed :because of the chronic diarrhea. It could happen in any patient with Chr.Diarrhea. Happen in 1/5 of Patients with CF. 12
13 Chronic diarrhea : because we don t have the enzymes needed for the digestion of food. So we will have High fatty and osmotic content that drain water and cause the diarrhea. Constipation : because of the thick secretions. Distal intestinal obstruction syndrome (DIOS): because of the thick secretions we will have constipation and obstruction. It s meconium ileus equivalent : inspissated material in ileum, cecum, proximal colon. It would present with picture of intestinal obstruction: abdominal pain, distension, air fluid levels. Intussusception : telescoping of the small intestine. The fecal material because of being thick will work as a lead point. It will present as Colicky abdominal pain, vomiting ( because of the obstruction ). Malnutrition/Kwashiorkor Failure to thrive Focal biliary cirrhosis Malabsorption : manifests as abdominal distention, flatulence and chronic diarrhea. Meconium ileus It s small bowel obstruction in first days of life. We will see dilated proximal bowel with small distal obstructed bowel. Also,it may require surgical resection and ultimate reanastomosis. In mild cases we can use gastrograffin. 13
14 Rectal Prolapse Malnutrition/Kwashiorkor It occurs due to also hypoalbuminemia that cause edema. *Manifestations : Greasy stool (Steatorrhea) Flatulence Abdominal bloating Poor weight gain Fat-soluble-vitamin deficiency Pancreatic Insufficiency 14
15 (A,D, E, K) - Vit A deficiency leads to night blindness - Vit D deficiency leads to osteopenia and osteoporosis (Late). - Vit E deficiency leads to haemolytic anemia and neuropathy. - Vit K deficiency increase the bleeding tendency. Malnutrition Assessment of Pancreatic Function 10-15% of Patients have mild CFTR mutations that result in pancreatic sufficient CF. so the assessment of pancreatic function id done by : 1. Serum trypsinogen: doesn t have a good sensitivity hour fecal fat collection : the nutritionist will quantify the fat intake and the fat excreted in the stool which should be only 7% or less. So 93% of the fate should be absorbed. It s not practical because it s not pleasant to collect stool for 3 days and it s time-consuming. 3. Fecal elastase : is the gold standard: sensitivity and specificity is 100% in CF and isn t affected by the pancreatic enzyme replacement. It will be decreased in CF patients. Biliary Tract Manifestations Biliary cirrhosis : symptomatic in 2-3%. Jaundice: due to thick secretions in the liver (especially neonatal jaundice). Ascites, hematemesis and esophageal varices due to portal hypertension (all are late signs & symptoms). Neonatal hepatitis. 15
16 Other CF Manifestations 1- CF-related Diabetes Mellitus (CFRD) : we mention it previously and 30% of CF patients will have it after the age of 25years. 2- Male infertility: Because of 1 Obstructive azoospermia (98%), 2 congenital bilateral absence of the vas deference (CBAVD) - Azoospermia: is the medical condition of a man not having any measurable level of sperm in his semen." Wikipedia 3- Salt depletion, metabolic alkalosis (Especially in hot areas because of excessive sweating ). 4- Digital clubbing : obliterated nail angle. Digital Clubbing Management Modalities the Dr slides and the record was so much not organized in the management part, so I put many things from the old lecture with some modifications. 16
17 1. Management of Pulmonary manifestations 2. Management of GI manifestations. 3. Preventive therapy. Management of Pulmonary manifestations A) Airway clearance : Is done mainly by Chest Physiotherapy which is is important and should be encouraged at home and at the hospital. Most of its practice involves 1 postural drainage (see figure below) and 2 positive expiratory pressure. During postural drainage, the child should try to keep his head and face down to get rid of secretions. Young children in general can't produce sputum and they tend to swallow normal secretions. B) Agents to promote airway secretion clearance: We put patients on nebulizers to liquefy the thick secretion in the airway. So we give: ** Inhaled Mucolytics : - Inhaled recombinant DNAse (dornase alfa) : it breaks the DNA of neutrophils and it s expensive medication. It s trade name is Pulmozyme and it s not available in Jordan that s why we use other medications. 17
18 - N-acetyl-L-cysteine ** Inhaled Hypertonic saline 7% : ( Also not available in Jordan, we have just the 2.7% concentration ). It acts as an osmotic agent ( high content of Na ) to drag water to the pericellular layer, thus improving the lung function test and reduce lung exacerbation. C) Antibiotic Therapy : To treat the infections. - Nebulized antibiotics. - IV antibiotics. For P.aeruginosa, we need at least 2 antibiotics and we need higher doses than the regular doses ( because we need high concentrations to reach the thick mucous layer ). Cystic fibrosis has higher incidence of asthma. Therefore, we have to give them bronchodilators and anti-inflammatory drugs. D) Anti-Inflammatory therapy High doses of ibuprofen proved to be beneficial but practically they are not used because they cause severe side effects like GI side effects : peptic ulcers and renal impairment. We can use also CS for bronchopulmonary aspergillosis. E) Bronchodilator therapy: Beta2 agonist. F) Macrolide antibiotics The Prototype that is used in CF patients is the azithromycin. It s used for its anti-inflammatory effect and It s indicated for P.arueginose-positive patients ( 3 times/week and we leave the patients on it even if they are asymptomatic ) because it reduces biofilm production (conversion of non-mucoid to mucoid ) and reduces virulence of P.aeruginosa (Bactericidal effect). It improves lung function and decreases exacerbations. 18
19 Pulmonary Exacerbations When do I said that this patient is getting an exacerbation? When : Increased cough, change in sputum colour or quantity Decreased appetite and weight Change in RR, presence of new crackles or wheezing Decline in lung function (FEV1 : if low, it reflect an abstructive disease ) Rx: Aggressive treatment (we give IV antibiotics at least 2, used with higher doses than usual for days ) : - Antibiotics - Increase airway clearance - Improve nutrition The Doctor showed a video about High frequency chest wall oscillation (trade name vest, cost 15000$ ) which is used for airways clearance. They wear it for 30minutes twice daily, then they enhance the patient to cough to clear the secretions. It s used also for neuromuscular diseases. Management of GI manifestations It s mainly By nutrition which should include : 1. High energy and calorie diet They need more than the regular amount of calories ( kcal/kg/day), they should take extra snacks and extra meals and they should take the enzymes with EVERY meal. We also encourage the high protein intake also food with high fat content. 2. Pancreatic enzyme replacement which are Enteric coated PH-resistant microsphere preparations to protect them from degradation by the stomach pepsin and this allow the release of the enzymes at ph of which is in the small intestine. 19
20 3. Fat-soluble vitamin supplementation and minerals. Vit A,D, E, K. and we should provide them with high energy and high calorie diet. Preventive Care -Annual influenza vaccine - Pneumococcal vaccine - RSV prophylaxis < 2 years (this summary from illustrated textbook of Pediatrics ) THANK YOU **Done By : Bara Al-Zu bi 20
Cystic Fibrosis. Jennifer McDaniel, BS, RRT-NPS
Cystic Fibrosis Jennifer McDaniel, BS, RRT-NPS Overview Cystic fibrosis is the most common fatal, inherited disease in the U. S. CF results from a defective autosomal recessive gene One copy of gene =
More informationFocus on Cystic Fibrosis. Cystic Fibrosis. Cystic Fibrosis
Focus on (Relates to Chapter 29, Nursing Management: Obstructive Pulmonary Diseases, in the textbook) Copyright 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. Autosomal recessive, multisystem
More informationWhat is Cystic Fibrosis? CYSTIC FIBROSIS. Genetics of CF
What is Cystic Fibrosis? CYSTIC FIBROSIS Lynne M. Quittell, M.D. Director, CF Center Columbia University Chronic, progressive and life limiting autosomal recessive genetic disease characterized by chronic
More informationA review of Cystic Fibrosis
A review of Cystic Fibrosis Jennifer Landry md F.R.C.P.(C) Pulmonary & Critical Care Medicine McGill University Health Center Cystic Fibrosis One of the most common lethal inherited AR disorders in the
More information"Management and Treatment of Patients with Cystic fibrosis (CF)
"Management and Treatment of Patients with Cystic fibrosis (CF) Dr. Malena Cohen-Cymberknoh Pediatric Pulmonology and CF Center Hadassah Hebrew-University Medical Center Jerusalem, Israel Afula, March
More informationCYSTIC FIBROSIS OBJECTIVES NO CONFLICT OF INTEREST TO DISCLOSE
CYSTIC FIBROSIS Madhu Pendurthi MD MPH Staff Physician, Mercy Hospital Springfield, MO NO CONFLICT OF INTEREST TO DISCLOSE OBJECTIVES Epidemiology of Cystic Fibrosis (CF) Genetic basis and pathophysiology
More informationUNDERSTANDING CYSTIC FIBROSIS
UNDERSTANDING CYSTIC FIBROSIS INTRODUCTION Cystic fibrosis is a chronic disease that affects the respiratory and gastrointestinal systems. People with cystic fibrosis have a genetic defect of the lungs
More informationRespiratory Pharmacology: Treatment of Cystic Fibrosis
Respiratory Pharmacology: Treatment of Cystic Fibrosis Dr. Tillie-Louise Hackett Department of Anesthesiology, Pharmacology and Therapeutics University of British Columbia Associate Head, Centre of Heart
More informationCystic Fibrosis. Parkland College. Monica Rahman Parkland College. Recommended Citation
Parkland College A with Honors Projects Honors Program 2013 Cystic Fibrosis Monica Rahman Parkland College Recommended Citation Rahman, Monica, "Cystic Fibrosis" (2013). A with Honors Projects. 98. http://spark.parkland.edu/ah/98
More informationFACTS ABOUT. Cystic Fibrosis. What Is Cystic Fibrosis. What Are the Signs and Symptoms of CF?
FACTS ABOUT Cystic Fibrosis What Is Cystic Fibrosis Cystic fibrosis (CF) is a chronic, progressive, and frequently fatal genetic (inherited) disease of the body s mucus glands. CF primarily affects the
More informationGoals Basic defect Pathophysiology Clinical i l signs and symptoms Therapy
CYSTIC FIBROSIS Lynne M. Quittell, M.D. Director, CF Center Columbia University Goals Basic defect Pathophysiology Clinical i l signs and symptoms Therapy What is Cystic Fibrosis? Chronic, progressive
More informationChanges in the management of children with Cystic Fibrosis. Caroline Murphy & Deirdre O Donovan CF Nurses
Changes in the management of children with Cystic Fibrosis Caroline Murphy & Deirdre O Donovan CF Nurses What Is Cystic Fibrosis? Cystic fibrosis (CF) is an inherited chronic disease that primarily affects
More informationCystic Fibrosis. Presented by: Chris Belanger & Dylan Medd
Cystic Fibrosis Presented by: Chris Belanger & Dylan Medd Outline What is Cystic Fibrosis? Signs, Symptoms & Diagnosis Who does it effect? General effects on daily life Managing Cystic Fibrosis Exercise
More informationEvaluation of Patients with Diffuse Bronchiectasis
Evaluation of Patients with Diffuse Bronchiectasis Dr. Patricia Eshaghian, MD Assistant Clinical Professor of Medicine Director, UCLA Adult Cystic Fibrosis Affiliate Program UCLA Division of Pulmonary
More informationCystic Fibrosis New Patient Binder Cystic Fibrosis Center Pediatric Pulmonary Division
An annotated table-of-contents for the Cystic Fibrosis New Patient Binder Pediatric Pulmonary Division Introduction This booklet is a summary of the key points in the detailed and comprehensive information
More informationCystic fibrosis: hitting the target
Cystic fibrosis: hitting the target Heartland Collaborative Annual Meeting Friday, October 5, 2012 Thomas Ferkol MD 1938 1953 Cystic fibrosis: a historical timeline Cystic fibrosis (CF) of the pancreas
More informationCystic Fibrosis. History of Cystic Fibrosis. History of Cystic Fibrosis. Cystic Fibrosis. Salty Kiss
Cystic Fibrosis History of Cystic Fibrosis Salty Kiss Dr Marleen Moens Revalidatiecentrum voor kinderen en jongeren, respiratoire afdeling UZ Gasthuisberg, mucoteam Leuven 1938 Anderson: cystic fibrosis
More informationCF: Information for Case Managers. Cindy Capen MSN, RN Pediatric Pulmonary Division University of Florida
CF: Information for Case Managers Cindy Capen MSN, RN capencl@peds.ufl.edu Pediatric Pulmonary Division University of Florida About your speaker 25+ years in pulmonary Coordinator for CF Center and CF
More informationChronic obstructive lung disease. Dr/Rehab F.Gwada
Chronic obstructive lung disease Dr/Rehab F.Gwada Obstructive lung diseases Problem is in the expiratory phase Lung disease Restrictive lung disease Restriction may be with, or within the chest wall Problem
More informationPULMONARY SURFACTANT, ALPHA 1 ANTITRYPSIN INHIBITOR DEFICIENCY, AND CYSTIC FIBROSIS DR. NABIL BASHIR BIOCHEMISTRY/RESPIRATORY SYSTEM
PULMONARY SURFACTANT, ALPHA 1 ANTITRYPSIN INHIBITOR DEFICIENCY, AND CYSTIC FIBROSIS DR. NABIL BASHIR BIOCHEMISTRY/RESPIRATORY SYSTEM Pulmonary surfactant Pulmonary surfactant is (phospholipoprotein) complex
More informationCystic Fibrosis. Information for Caregivers
Cystic Fibrosis Information for Caregivers Arkansas Children s Hospital is an accredited Cystic Fibrosis Care Center by the National Cystic Fibrosis Foundation Cystic Fibrosis: Information for Caregivers
More informationCystic Fibrosis the future
Cystic Fibrosis the future Pathophysiologic cascade Abnormal Gene Abnormal CFTR Therapy Gene replacement Protein replacement Gene read through therapy Abnormal sodium chloride & water movement through
More informationNational Horizon Scanning Centre. Mannitol dry powder for inhalation (Bronchitol) for cystic fibrosis. April 2008
Mannitol dry powder for inhalation (Bronchitol) for cystic fibrosis April 2008 This technology summary is based on information available at the time of research and a limited literature search. It is not
More informationCaring for a person with cystic fibrosis
Caring for a person with cystic fibrosis Item Type Article Authors McDonagh, Yvonne;Meagher, Catherine Publisher Green Cross Publishing Journal Nursing in General Practice Download date 01/09/2018 03:18:31
More information10/05/2017. Learning Objectives. Etiology and Prevalence. Diagnosis of Cystic Fibrosis. Disease of Childhood? Survival in Cystic Fibrosis
Management of the Cystic Fibrosis Patient Jessica Goggin, MAS, RN Nurse Manager UC San Diego Adult Cystic Fibrosis Program Learning Objectives 1. Describe the symptoms associated with Cystic Fibrosis (CF).
More informationCase Study What is the Relationship Between the Cell Membrane and Cystic Fibrosis?
Names: Date: Case Study What is the Relationship Between the Cell Membrane and Cystic Fibrosis? Dr. Weyland examined a six month old infant that had been admitted to University Hospital earlier in the
More informationWhat is the inheritance pattern (e.g., autosomal, sex-linked, dominant, recessive, etc.)?
Module I: Introduction to the disease Give a brief introduction to the disease, considering the following: the symptoms that define the syndrome, the range of phenotypes exhibited by individuals with the
More informationAnatomy of the biliary tract
Harvard-MIT Division of Health Sciences and Technology HST.121: Gastroenterology, Fall 2005 Instructors: Dr. Jonathan Glickman Anatomy of the biliary tract Figure removed due to copyright reasons. Biliary
More informationContents. In this lecture, we will discuss: Tuberculosis. Asthma. Cystic fibrosis. Bronchopulmonary dysplasia. Miss.kamlah
1 Contents In this lecture, we will discuss: Tuberculosis. Asthma. Cystic fibrosis. Bronchopulmonary dysplasia. 2 Tuberculosis (TB) is caused by organism Mycobacterium tuberculosis, which is transmitted
More informationFOR GENERAL PRACTITIONERS
INFORMATION PACK FOR GENERAL PRACTITIONERS Presented by 2 CONTENTS Chapter Page No 1. What is Cystic Fibrosis (CF)?... 5 Definition Symptoms The Digestive System Signs & Symptoms Breast Feeding & Cystic
More informationUK Cystic Fibrosis Registry
UK Cystic Fibrosis Registry Annual Data Report 2017 Scotland UK Cystic Fibrosis Registry 2017 Annual Data Report - Scotland Report prepared by Andrew Lee Statistician Cystic Fibrosis Trust Susan Charman
More informationA Case of Cystic Fibrosis
Name(s) Date A Case of Cystic Fibrosis Dr. Weyland examined a six month old infant that had been admitted to University Hospital earlier in the day. The baby's parents had brought young Zoey to the emergency
More informationPediatrics Grand Rounds 13 November University of Texas Health Science Center at San Antonio. Learning Objectives
Nationwide Newborn Screening for Cystic Fibrosis: Finally Creating an Opportunity for All Patients to Have Better Outcomes Philip M Farrell, MD, PhD* University of Wisconsin-Madison *No disclosures other
More informationGastroenterology. Certification Examination Blueprint. Purpose of the exam
Gastroenterology Certification Examination Blueprint Purpose of the exam The exam is designed to evaluate the knowledge, diagnostic reasoning, and clinical judgment skills expected of the certified gastroenterologist
More informationChapter 3 The Role of Nutrition in CF Care
Chapter 3 The Role of Nutrition in CF Care S. King, N. Saxby & N. Sander Cystic fibrosis is the most common lethal autosomal recessive genetic condition affecting Caucasians 186,187. Over 3500 Australians
More informationCystic Fibrosis as it relates to the neonate MARIANNE MUHLEBACH, MD PROFESSOR, DEPT. PEDIATRICS UNC CHAPEL HILL
Cystic Fibrosis as it relates to the neonate MARIANNE MUHLEBACH, MD PROFESSOR, DEPT. PEDIATRICS UNC CHAPEL HILL Objectives: At the end of the presentation the listeners will Be able to describe neonatal
More informationCYSTIC FIBROSIS Risk Factors Epidemiology Pathogenesis Defective protein synthesis (10%) Abnormal protein folding, processing & trafficking
CYSTIC FIBROSIS Risk Factors Caucasian Family history of CF Infection Exposure to allergens and tobacco Epidemiology Carrier frequency of 1 in 25 for Caucasians The most common lethal genetic disease affecting
More informationTEST INFORMATION Test: CarrierMap GEN (Genotyping) Panel: CarrierMap Expanded Diseases Tested: 311 Genes Tested: 299 Mutations Tested: 2647
Ordering Practice Jane Smith John Smith Practice Code: 675 Miller MD 374 Broadway New York, NY 10000 Physician: Dr. Frank Miller Report Generated: 2016-02-03 DOB: 1973-02-19 Gender: Female Ethnicity: European
More informationChronic lung diseases in children Simple choice 1. Finger clubbing is not characteristic for: a) Diffuse bronchiectasis b) Cystic fibrosis c)
Chronic lung diseases in children Simple choice 1. Finger clubbing is not characteristic for: a) Diffuse bronchiectasis b) Cystic fibrosis c) Bronchiolitis obliterans d) Complicated acute pneumonia e)
More informationClinical Commissioning Policy Proposition: Dornase alfa inhaled therapy for primary ciliary dyskinesia (all ages)
Clinical Commissioning Policy Proposition: Dornase alfa inhaled therapy for primary ciliary dyskinesia (all ages) Reference: NHS England E03X05/01 Information Reader Box (IRB) to be inserted on inside
More informationRhianna Cenci, Sodexo Dietetic Intern
Rhianna Cenci, Sodexo Dietetic Intern Objectives Overview of CF and Treatments CF Medical Nutrition Therapy CF Case Study Cystic Fibrosis (CF) Overview Inherited chronic disease Produces unusually thick
More informationA Place For Airway Clearance Therapy In Today s Healthcare Environment
A Place For Airway Clearance Therapy In Today s Healthcare Environment Michigan Society for Respiratory Care 2015 Fall Conference K. James Ehlen, MD October 6, 2015 Objectives Describe patients who will
More informationE-BOOK # PANCREATIC ENZYMES FOR CYSTIC FIBROSIS ARCHIVE
10 June, 2018 E-BOOK # PANCREATIC ENZYMES FOR CYSTIC FIBROSIS ARCHIVE Document Filetype: PDF 220.67 KB 0 E-BOOK # PANCREATIC ENZYMES FOR CYSTIC FIBROSIS ARCHIVE If you have a systemic illness like lupus
More informationCystic fibrosis: From childhood to adulthood. Eitan Kerem Department of Pediatrics and CF Center Hadassah University Hospital Jerusalem Israel
Cystic fibrosis: From childhood to adulthood Eitan Kerem Department of Pediatrics and CF Center Hadassah University Hospital Jerusalem Israel Vas deference H 2 O Cl - Na + H 2 O Na + Cl - Cl - Cl -
More informationSoft palate elevates, closing off the nasopharynx. Hard palate Tongue Bolus Epiglottis. Glottis Larynx moves up and forward.
The Cephalic Phase Chemical and mechanical digestion begins in the mouth Saliva is an exocrine secretion Salivary secretion is under autonomic control Softens and lubricates food Chemical digestion: salivary
More informationClinical Commissioning Policy: Dornase alfa inhaled therapy for primary ciliary dyskinesia (all ages)
Clinical Commissioning Policy: Dornase alfa inhaled therapy for primary ciliary dyskinesia (all ages) Reference: NHS England: 16029/P NHS England INFORMATION READER BOX Directorate Medical Operations and
More informationCystic Fibrosis Complications ANDRES ZIRLINGER, MD STANFORD UNIVERSITY MEDICAL CENTER MARCH 3, 2012
Cystic Fibrosis Complications ANDRES ZIRLINGER, MD STANFORD UNIVERSITY MEDICAL CENTER MARCH 3, 2012 INTRODUCTION PNEUMOTHORAX HEMOPTYSIS RESPIRATORY FAILURE Cystic Fibrosis Autosomal Recessive Genetically
More informationRespiratory Disorders. Dr Tanya Robertson
Respiratory Disorders Dr Tanya Robertson Aims Overview of respiratory problems in children Diagnosis Management Asthma Cystic fibrosis Why are children different? Immune status Structure and function respiratory
More informationWeek 3 The Pancreas: Pancreatic ph buffering:
Week 3 The Pancreas: A gland with both endocrine (secretion of substances into the bloodstream) & exocrine (secretion of substances to the outside of the body or another surface within the body) functions
More informationOverview of Cystic fibrosis in children. Apeksha Sathyaprasad, MD Pediatric pulmonologist
Overview of Cystic fibrosis in children Apeksha Sathyaprasad, MD Pediatric pulmonologist No conflicts of interest OBJECTIVES Review pathophysiology of pulmonary disease in cystic fibrosis Review diagnostic
More informationPediatrics Grand Rounds 18 Sept University of Texas Health Science Center. + Disclosure. + Learning Objectives.
Disclosure Dr Donna Willey Courand receives research support from Cystic Fibrosis Therapeutics The Cystic Fibrosis Foundation Children with Special Health Care Needs Cystic Fibrosis 05: Improving Survival
More informationCystic Fibrosis a) Diagnostic Dilemmas b) The New Problems. Dr Mark Rosenthal Royal Brompton Hospital London
Cystic Fibrosis a) Diagnostic Dilemmas b) The New Problems Dr Mark Rosenthal Royal Brompton Hospital London So what exactly is CF? A genetic diagnosis An electrolyte diagnosis An electrical diagnosis A
More informationYou Can Observe a Lot By Just Watching. Wayne J. Morgan, MD, CM
You Can Observe a Lot By Just Watching Wayne J. Morgan, MD, CM Disclosures Genentech Epidemiological Study of Cystic Fibrosis, Scientific Advisory Group CF Foundation Data Safety Monitoring Board Registry/Comparative
More informationDiseases of the gastrointestinal system. H Awad Lecture 2: small intestine/ part 2 and appendix
Diseases of the gastrointestinal system H Awad Lecture 2: small intestine/ part 2 and appendix Malabsorption most important causes of malabsorption: Celiac disease tropical sprue Lactase deficiency Whipple
More informationPATIENT EDUCATION. Cystic Fibrosis Carrier Testing
PATIENT EDUCATION Cystic Fibrosis Carrier Testing Introduction Cystic fibrosis carrier testing before or during pregnancy can help determine your risk of having a child with cystic fibrosis. This information
More informationDigestive System 7/15/2015. Outline Digestive System. Digestive System
Digestive System Biology 105 Lecture 18 Chapter 15 Outline Digestive System I. Functions II. Layers of the GI tract III. Major parts: mouth, pharynx, esophagus, stomach, small intestine, large intestine,
More informationNon-CF bronchiectasis: Alexander Duarte, MD Pulmonary, Critical Care & Sleep Medicine University of Texas Medical Branch Galveston, TX
Non-CF bronchiectasis: Alexander Duarte, MD Pulmonary, Critical Care & Sleep Medicine University of Texas Medical Branch Galveston, TX Pioneer of Respiratory Medicine 2016 marked 200th anniversary of his
More informationBronchiectasis. Examples include: Viral infections (measles, adenovirus, influenza)
Bronchiectasis What is Bronchiectasis? Bronchiectasis (pronounced bron-kee-ek'-tas-is) is a condition of the airways in the lungs. These airways (bronchial tubes) are tubelike structures that branch from
More informationBronchiectasis in Adults - Suspected
Bronchiectasis in Adults - Suspected Clinical symptoms which may indicate bronchiectasis for patients Take full respiratory history including presenting symptoms, past medical & family history Factors
More informationGASTROENTEROLOGY Maintenance of Certification (MOC) Examination Blueprint
GASTROENTEROLOGY Maintenance of Certification (MOC) Examination Blueprint ABIM invites diplomates to help develop the Gastroenterology MOC exam blueprint Based on feedback from physicians that MOC assessments
More informationBronchiectasis. What is bronchiectasis? What causes bronchiectasis?
This factsheet explains what bronchiectasis is, what causes it, and how it is diagnosed and managed. More detailed information is available on the Bronchiectasis Patient Priorities website: www.europeanlunginfo.org/bronchiectasis
More informationCystic Fibrosis. Advances and Asian Perspective Dr AS Paul 13 October 06
Cystic Fibrosis Advances and Asian Perspective Dr AS Paul 13 October 06 Cystic Fibrosis An Overview Asian Perspective Advances Cystic Fibrosis An Overview Epidemiology and Pathogenesis Most common severe
More informationCystic Fibrosis: Progress in Treatment Management. Patrick A. Flume, M.D. Medical University of South Carolina
Cystic Fibrosis: Progress in Treatment Management Patrick A. Flume, M.D. Medical University of South Carolina Disclosures Grant support Mpex Pharmaceuticals, Inc Gilead Sciences, Inc Bayer Healthcare AG
More informationTHE ROLE OF CFTR MUTATIONS IN CAUSING CYSTIC FIBROSIS (CF)
THE ROLE OF CFTR MUTATIONS IN CAUSING CYSTIC FIBROSIS (CF) Vertex Pharmaceuticals Incorporated, 50 Northern Avenue, Boston, MA 02210. Vertex and the Vertex triangle logo are registered trademarks for Vertex
More informationCystic Fibrosis Carrier Testing
PATIENT EDUCATION Cystic Fibrosis Carrier Testing Introduction Cystic fibrosis carrier testing before or during pregnancy can help determine your risk of having a child with cystic fibrosis. This information
More informationDigestion and Absorption
Digestion and Absorption Digestion and Absorption Digestion is a process essential for the conversion of food into a small and simple form. Mechanical digestion by mastication and swallowing Chemical digestion
More informationCystic Fibrosis Foundation Patient Registry 2013
5/9/2015 Targeting CFTR to Treat Cystic Fibrosis: Small Molecule Therapy Mary Ellen Kleinhenz, MD Director, UCSF Adult Cystic Fibrosis Program Professor of Medicine UCSF Division of Pulmonary, Critical
More informationPATHOLOGY MCQs. The Pancreas
PATHOLOGY MCQs The Pancreas A patient with cystic fibrosis is characteristically: A. more than 45 years of age B. subject to recurring pulmonary infections C. obese D. subject to spontaneous fractures
More informationSaliva & Feces analysis
Saliva & Feces analysis Saliva analysis What is Saliva? Watery substance present in humans and animals and secreted by salivary glands and aids in digestion It is a filtrate of plasma Contains electrolytes,
More informationCystic Fibrosis Care Guidelines for Challenging Cystic Fibrosis
Cystic Fibrosis Care Guidelines for Challenging Cystic Fibrosis APRIL 2018 Authors Steve Kent MD, CF Clinic Director, Victoria General Hospital (VGH), Victoria Mark Chilvers MD, CF Clinic Director, B.C.
More informationCystic Fibrosis. Cystic Fibrosis. Cystic Fibrosis 5/01/2011 CYSTIC FIBROSIS OF THE PANCREAS AND ITS RELATION TO CELIAC DISEASE. D ANDERSEN.
1938 OF THE PANCREAS AND ITS RELATION TO CELIAC DISEASE. D ANDERSEN. American Journal Diseases Children. : The beginning May 1938: 49 cases 25 20 15 Nos of cases 10 5 0 0.5 1 1.5 2 2.5 3 3.5 4 4.5 5 Age
More informationAdvances in CF therapies and their effect on GI manifestations. Presenter Disclosure Daniel Gelfond, MD Relationship related to this presentation
Advances in CF therapies and their effect on GI manifestations Daniel Gelfond, MD University of Rochester WNY Pediatric Gastroenterology Presenter Disclosure Daniel Gelfond, MD Relationship related to
More informationSection Coordinator: Jerome W. Breslin, PhD, Assistant Professor of Physiology, MEB 7208, ,
IDP Biological Systems Gastrointestinal System Section Coordinator: Jerome W. Breslin, PhD, Assistant Professor of Physiology, MEB 7208, 504-568-2669, jbresl@lsuhsc.edu Overall Learning Objectives 1. Characterize
More informationNutritional Support for Cystic Fibrosis
Nutritional Support for Cystic Fibrosis The global incidence of cystic fibrosis is estimated as 1/2500 live births. CF cannot be cured, but the symptoms can be managed to support overall health, to manage
More informationCaregiver burden and quality of life of parents of young children with cystic fibrosis
Caregiver burden and quality of life of parents of young children with cystic fibrosis Professor Patricia Fitzpatrick 1 S George 1, R Somerville 1, B Linnane 2, C Fitzgerald 1 1 UCD School of Public Health,
More informationHAVE YOU RECENTLY MOVED? PLEASE NOTIFY US.
W-F Professional Associates, Inc. 400 Lake Cook Rd., Suite 207 Deerfield, IL 60015 847-945-8050 April 2003 Pharmacy Perspective: Cystic Fibrosis 707-000-03-004-H01 MISSING A LESSON? IT S EASY TO GO TO
More informationMalabsorption Syndromes in Children
Malabsorption Syndromes in Children Oxana Turcu, PhD, assistant professor Department of Pediatrics Malabsorption syndromes include a number of different clinical manifestations, that result in chronic
More informationPathophysiology. Tutorial 1 Genetic Diseases
Pathophysiology Tutorial 1 Genetic Diseases ILOs Analyze genetic pedigrees and recognize the mode of inheritance of diseases. Differentiate between patterns of inheritance based on the type of the protein
More informationClinical Commissioning Policy: Levofloxacin nebuliser solution for chronic Pseudomonas lung infection in cystic fibrosis (all ages)
Clinical Commissioning Policy: Levofloxacin nebuliser solution for chronic Pseudomonas lung infection in cystic fibrosis (all ages) NHS England Reference: 1732P NHS England INFORMATION READER BOX Directorate
More informationCystic fibrosis: From the gene to the disease
Cystic fibrosis: From the gene to the disease Christiane Knoop, MD, PhD Institut de Mucoviscidose de l ULB Hôpital Erasme christiane.knoop@erasme.ulb.ac.be Cystic fibrosis «The infant that tastes of salt
More informationWelcome to Nutrition Management of Cystic Fibrosis by Lolita McLean, MPH, RDN; Connie Martin, MS, RDN; and Claire Stephens, MS, RDN...
Welcome to Nutrition Management of Cystic Fibrosis by Lolita McLean, MPH, RDN; Connie Martin, MS, RDN; and Claire Stephens, MS, RDN...all of Alabama s Children s Rehabilitation Service, or CRS, part of
More informationLiver Disease in Cystic Fibrosis
Liver Disease in Cystic Fibrosis Basic Overview Clinical Aspects Management What Is Cystic Fibrosis? Autosomal recessive disease W-1:3000, H-1:10,000, AA-1:15,000 Mutations of CFTR defective Cl - transport
More informationFriday, January 4. Bell Work:
Friday, January 4 Bell Work: Red green colorblindness is an X linked trait and is recessive. A male who is normal marries a woman who is a carrier, what is the phenotypic ratio of their offspring? 1 Genetic
More informationChapter 15. Cardiovascular, Respiratory, Digestive Systems
Chapter 15 Cardiovascular, Respiratory, Digestive Systems Cardiovascular/Respiratory Systems Cardiovascular System Blood is pumped to the body 24/7 Heart s tasks: Carries oxygen from lungs to body cells
More informationEpiglottitis. Bronchitis. Bronchiolitis. Pneumonia. Croup syndrome. Miss. kamlah 2
Miss. kamlah 1 Epiglottitis. Bronchitis. Bronchiolitis. Pneumonia. Croup syndrome. Miss. kamlah 2 Acute Epiglottitis Is an infection of the epiglottis, the long narrow structure that closes off the glottis
More informationChapter 2: Human Body Systems Work Independently and Together
Chapter 2: Human Body Systems Work Independently and Together 2.1 Body Systems Body systems Are made up of parts that work together as a whole Are connected to one or more other Will not function well
More informationDiseases of exocrine pancreas
Diseases of exocrine pancreas The exocrine pancreas constitutes 80% to 85% of the organ and is composed of acinar cells that secrete enzymes needed for digestion. the accessory duct of Santorini, the main
More informationMy dog or cat has problems with the stomach, intestines or liver... what do I do now?
Dietary food for the targeted tackling of gastrointestinal and/or liver problems in dogs and cats My dog or cat has problems with the stomach, intestines or liver... what do I do now? reliable and and
More informationWhat location in the gastrointestinal (GI) tract has tight, or impermeable, junctions between the epithelial cells?
CASE 32 A 17-year-old boy presents to his primary care physician with complaints of diarrhea for the last 2 days. The patient states that he just returned to the United States after visiting relatives
More informationNOTES: The Digestive System (Ch 14, part 2)
NOTES: The Digestive System (Ch 14, part 2) PANCREAS Structure of the pancreas: The pancreas produces PANCREATIC JUICE that is then secreted into a pancreatic duct. The PANCREATIC DUCT leads to the The
More informationChronic Diarrhea in Dogs
Chronic Diarrhea in Dogs Basics OVERVIEW A change in the frequency, consistency, and volume of bowel movement (feces) for more than 3 weeks Can be either small bowel (small intestine) diarrhea, large bowel
More informationCF WORDS TO KNOW. Glossary (v4)
abdomen through adolescents CF WORDS TO KNOW Glossary (v4) A Abdomen Also called the belly. The part of the body below the diaphragm and above the pelvis where the digestive tract, liver, and kidneys are
More informationEsophageal Disorders. Gastrointestinal Diseases. Peptic Ulcer Disease. Wireless capsule endoscopy. Diseases of the Small Intestine 7/24/2010
Esophageal Disorders Gastrointestinal Diseases Fernando Vega, MD HIHIM 409 Dysphagia Difficulty Swallowing and passing food from mouth via the esophagus Diagnostic aids: Endoscopy, Barium x ray, Cineradiology,
More informationPediatric Gastroenterology Referral Guidelines
Suggested Pre-Referral Workup This is a general suggestion of possible testing to confirm a suspected diagnosis. Although referrals will be accepted without the suggested work up being complete, to ensure
More informationDigestive Care Advisor Training #1. Digestion 101 & H.O.P.E.
Digestive Care Advisor Training #1 & H.O.P.E. The Digestive System in Brief The Process of Digestion The human digestive system is a complex series of organs and glands that process food and excrete waste.
More informationCystic Fibrosis Diagnosis and Treatment
Cystic Fibrosis Diagnosis and Treatment Financial Disclosures Personal financial relationships with commercial interests relevant to medicine, within the past 3 years: NJH site PI for AstraZeneca. As faculty
More informationCOMMON VARIABLE IMMUNODEFICIENCY
COMMON VARIABLE IMMUNODEFICIENCY This booklet is intended for use by patients and their families and should not replace advice from a clinical immunologist. 1 COMMON VARIABLE IMMUNODEFICIENCY Also available
More informationInstrumental determination of electrolytes in urine. Amal Alamri
Instrumental determination of electrolytes in urine Amal Alamri What is the Electrolytes? Electrolytes are positively and negatively chargedions, Found in Within body's cells extracellular fluids, including
More informationCystic fibrosis and anaesthesia
Marianne Fitzgerald MRCSI FCARCSI Donal Ryan MRCPI FCARCSI FCICM Matrix reference 2A03, 3D00 Key points Cystic fibrosis (CF) is the most common, lethal genetic disease in Caucasians. The Republic of Ireland
More informationAsthma. - A chronic inflammatory disorder which causes recurrent episodes of wheezing, breathlessness, cough and chest tightness.
Obstructive diseases Asthma - A chronic inflammatory disorder which causes recurrent episodes of wheezing, breathlessness, cough and chest tightness. - Characterized by Intermittent and reversible (the
More information